Novel Cardiac Signal Processing System

Overview

About this study

This study involves the use of the Pure EP system in parallel to standard cardiac signal equipment during cardiac ablation procedures. The recordings/mapping from both systems will be reviewed and compared to determine if the Pure EP system can provide better or clearer diagnostic information.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Indication for cardiac ablation treatment.
Signed informed consent.

Exclusion Criteria:

Contraindication to electrophysiology study or ablation.
Enrollment in any other ongoing arrhythmia study protocol.
Active Infection or sepsis.
Pregnancy or lactation.
≤ 18 years of age.

Eligibility last updated 9/17/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Christopher McLeod, M.B., Ch.B., Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Christopher McLeod, M.B., Ch.B., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials